These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 25005526
1. Antitumor effect of Kanglaite® injection in human pancreatic cancer xenografts. Liu Y, Zhang W, Wang XJ, Liu S. BMC Complement Altern Med; 2014 Jul 08; 14():228. PubMed ID: 25005526 [Abstract] [Full Text] [Related]
2. PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells. Liu S, Wang XJ, Liu Y, Cui YF. Am J Chin Med; 2013 Jul 08; 41(3):629-42. PubMed ID: 23711146 [Abstract] [Full Text] [Related]
3. Chloroform extract from Sophora Tonkinensis Gagnep. inhibit proliferation, migration, invasion and promote apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway. ShuoWang, Song Z, Gong X, Ou C, Zhang W, Wang J, Yao C, Qin S, Yan B, Li Q, Wei K, Hou X, Zhou X, Miao J. J Ethnopharmacol; 2021 May 10; 271():113879. PubMed ID: 33524509 [Abstract] [Full Text] [Related]
4. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway. Fu J, Zhu SH, Xu HB, Xu YQ, Wang X, Wang J, Kong PS. J Ethnopharmacol; 2020 Oct 28; 261():113071. PubMed ID: 32603676 [Abstract] [Full Text] [Related]
5. Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway. Chen S, Yao L. Cancer Chemother Pharmacol; 2021 Aug 28; 88(2):323-334. PubMed ID: 33978839 [Abstract] [Full Text] [Related]
6. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway. Zhou J, Jiang YY, Chen H, Wu YC, Zhang L. Cell Prolif; 2020 Feb 28; 53(2):e12739. PubMed ID: 31820522 [Abstract] [Full Text] [Related]
7. Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling. Cui J, Guo Y, Wu H, Xiong J, Peng T. Mol Med; 2021 Apr 13; 27(1):38. PubMed ID: 33849427 [Abstract] [Full Text] [Related]
8. Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway. Lin M, Xiao Y, Dai Y, Mao Y, Xu L, Zhang Q, Chen Z. Clin Transl Oncol; 2024 Apr 13; 26(4):951-965. PubMed ID: 37848695 [Abstract] [Full Text] [Related]
10. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells. Peng Y, Li L, Huang M, Duan C, Zhang L, Chen J. Cell Signal; 2014 Dec 13; 26(12):2782-92. PubMed ID: 25193113 [Abstract] [Full Text] [Related]
11. Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells. Xu Z, Zhang Y, Jiang J, Yang Y, Shi R, Hao B, Zhang Z, Huang Z, Kim JW, Zhang G. BMC Cancer; 2010 Apr 27; 10():161. PubMed ID: 20423485 [Abstract] [Full Text] [Related]
12. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy. Song J, Xu J, Guo J, Shang Y, Wang J, Wang T. Acta Histochem; 2021 Sep 27; 123(6):151769. PubMed ID: 34416437 [Abstract] [Full Text] [Related]
13. S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton. Zhang C, Yang N, Yang CH, Ding HS, Luo C, Zhang Y, Wu MJ, Zhang XW, Shen X, Jiang HL, Meng LH, Ding J. PLoS One; 2009 Sep 27; 4(3):e4881. PubMed ID: 19293927 [Abstract] [Full Text] [Related]
14. Jolkinolide B induces apoptosis in MCF-7 cells through inhibition of the PI3K/Akt/mTOR signaling pathway. Xu HY, Chen ZW, Hou JC, Du FX, Liu JC. Oncol Rep; 2013 Jan 27; 29(1):212-8. PubMed ID: 23129237 [Abstract] [Full Text] [Related]
15. CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis. Subramaniam D, Periyasamy G, Ponnurangam S, Chakrabarti D, Sugumar A, Padigaru M, Weir SJ, Balakrishnan A, Sharma S, Anant S. Mol Cancer Ther; 2012 Jul 27; 11(7):1598-608. PubMed ID: 22532602 [Abstract] [Full Text] [Related]
16. Deoxyshikonin isolated from Arnebia euchroma inhibits colorectal cancer by down-regulating the PI3K/Akt/mTOR pathway. Zhu Y, Zhong Y, Long X, Zhu Z, Zhou Y, Ye H, Zeng X, Zheng X. Pharm Biol; 2019 Dec 27; 57(1):412-423. PubMed ID: 31230505 [Abstract] [Full Text] [Related]
17. Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway. Boreddy SR, Pramanik KC, Srivastava SK. Clin Cancer Res; 2011 Apr 01; 17(7):1784-95. PubMed ID: 21350002 [Abstract] [Full Text] [Related]
18. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth. Sharma N, Nanta R, Sharma J, Gunewardena S, Singh KP, Shankar S, Srivastava RK. Oncotarget; 2015 Oct 13; 6(31):32039-60. PubMed ID: 26451606 [Abstract] [Full Text] [Related]
19. Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway. Liu Y, Bi T, Wang Z, Wu G, Qian L, Gao Q, Shen G. Apoptosis; 2016 Dec 13; 21(12):1398-1407. PubMed ID: 27671687 [Abstract] [Full Text] [Related]
20. BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy. Cao W, Liu X, Zhang Y, Li A, Xie Y, Zhou S, Song L, Xu R, Ma Y, Cai S, Tang X. Biomed Res Int; 2021 Dec 13; 2021():5556306. PubMed ID: 33987439 [Abstract] [Full Text] [Related] Page: [Next] [New Search]